skip to content

Cambridge Academy of Therapeutic Sciences

Read more at: Industry Experts in Residence (EiRs)

Industry Experts in Residence (EiRs)

The Industry Experts in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with...

Read more

Read more at: WT Access to Expertise

WT Access to Expertise

Applications are invited to apply for flexible funds, awarded to the University of Cambridge by the Wellcome Trust, through an Institutional Translational Partnership Award (iTPA). The funds are to support the outsourcing of expertise (consultancy) for ongoing and new projects in order to accelerate the development of...

Read more


Latest news

Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

8 September 2020

The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19. The study is one of three new UK-wide studies receiving a share of £8.4 million from UK Research...

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

8 September 2020

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease. PCR and antibody tests both have limitations...

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital

8 September 2020

Antiretroviral therapy (ART) failure and drug resistance are extremely common in patients living with HIV who are admitted to hospital in Malawi, according to new research published in Lancet HIV . These important findings highlight the threat posed by drug resistant HIV and call for rapid tests for drug resistant virus...